In view of the established extrapulmonary cancer sites targeted by smoking
a multiplicity of compounds and mechanisms might be involved. It has been d
ebated that smoking caused increased incidence of N-methylvaline at the N-t
erminus of haemoglobin. Because this could indicate a relevance of methylat
ing nitrosamines in tobacco smoke, data are presented from an industrial co
hort of 35 smokers and 21 non-smokers repeatedly monitored between 1994 and
1999. In general, N-methylvaline adduct levels in haemoglobin of smokers w
ere approximately 50% higher than those of non-smokers. The smoking-induced
methylation of haemoglobin is likely to be caused by dimethylnitrosamine (
N-nitroso-dimethylamine), a major nitrosamine in side-stream tobacco smoke.
The biomonitoring data emphasise the potential value of N-methylvaline as
a smoking-related biomarker and call for intensified research on tobacco sm
oke compounds that lead to macromolecular methylation processes.